CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 85 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,053 | -98.5% | 18,580 | -97.8% | 0.00% | -100.0% |
| Q3 2022 | $136,000 | -40.9% | 827,240 | -9.1% | 0.00% | -40.0% |
| Q2 2022 | $230,000 | -52.7% | 910,006 | -0.5% | 0.01% | -44.4% |
| Q1 2022 | $486,000 | -16.6% | 914,887 | -3.4% | 0.01% | -10.0% |
| Q4 2021 | $583,000 | -40.8% | 947,083 | -2.0% | 0.01% | -44.4% |
| Q3 2021 | $985,000 | -46.1% | 966,014 | -3.2% | 0.02% | -45.5% |
| Q2 2021 | $1,827,000 | -5.7% | 998,229 | +1.5% | 0.03% | -10.8% |
| Q1 2021 | $1,937,000 | +64.4% | 983,279 | +4.4% | 0.04% | +54.2% |
| Q4 2020 | $1,178,000 | -43.7% | 942,079 | -19.0% | 0.02% | -52.0% |
| Q3 2020 | $2,094,000 | -79.3% | 1,163,430 | -3.4% | 0.05% | -79.9% |
| Q2 2020 | $10,105,000 | +57.6% | 1,204,407 | -1.6% | 0.25% | +27.7% |
| Q1 2020 | $6,413,000 | – | 1,223,777 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |